GLP-1 Summit 2025
US$ 23.37
glp 1 agonists and inflammation Frontiers GLP-1 receptor agonists effective for
Description
Case reports have indicated that development of severe or disabling arthralgia may occur after days or years following of DPP-4 inhibitor initiation
Hoosein NM, Gurd RS
Patients with a history of pancreatitis face substantially higher recurrence risk and should discuss alternative treatments with their healthcare provider, as FDA labeling advises considering other therapies in this population
In landmark trials such as LEADER and SUSTAIN-6, liraglutide significantly lowered the risk of cardiovascular death, non-fatal myocardial infarction, and stroke by 13% compared to placebo (Marso et al., 2016a)
